Prophylactic Indomethacin Compared with Delayed Conservative Management of the Patent Ductus Arteriosus in Extremely Preterm Infants: Effects on Neonatal Outcomes

Journal of Pediatrics

Volumn 187, Issue , 2017, Pages 119-126.e1

  Liebowitz, Melissa ^a   Clyman, Ronald I ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

bronchopulmonary dysplasia; necrotizing enterocolitis; newborn; premature birth; retinopathy of prematurity

Indexed keywords

BEVACIZUMAB; INDOMETACIN; PARACETAMOL; PROSTAGLANDIN SYNTHASE INHIBITOR;

ARTICLE; BRAIN HEMORRHAGE; COHORT ANALYSIS; CONSERVATIVE TREATMENT; CONTROLLED STUDY; DISEASE DURATION; ECHOCARDIOGRAPHY; FEMALE; GESTATIONAL AGE; HUMAN; INCIDENCE; LOADING DRUG DOSE; LUNG DYSPLASIA; MAJOR CLINICAL STUDY; MALE; NECROTIZING ENTEROCOLITIS; NEONATOLOGIST; NEWBORN; NEWBORN MORBIDITY; PATENT DUCTUS ARTERIOSUS; PREMATURITY; PRIORITY JOURNAL; PROSPECTIVE STUDY; RETROLENTAL FIBROPLASIA; TREATMENT OUTCOME; BRONCHOPULMONARY DYSPLASIA; DUCTUS ARTERIOSUS, PATENT; PROCEDURES;

BRONCHOPULMONARY DYSPLASIA; COHORT STUDIES; CONSERVATIVE TREATMENT; CYCLOOXYGENASE INHIBITORS; DUCTUS ARTERIOSUS, PATENT; ECHOCARDIOGRAPHY; FEMALE; HUMANS; INCIDENCE; INDOMETHACIN; INFANT, EXTREMELY PREMATURE; INFANT, NEWBORN; MALE; PROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 85017142202     PISSN: 00223476     EISSN: 10976833     Source Type: Journal    
DOI: 10.1016/j.jpeds.2017.03.021     Document Type: Article

References (36)

1. Al Faleh, K., Smyth, J., Roberts, R., Solimano, A., Asztalos, E., Schmidt, B., Prevention and 18-month outcome of serious pulmonary hemorrhage in extremely low birth weight infants: results from the trial of indomethacin prophylaxis in preterms. Pediatrics 121 (2008), e233–8.
2. Kluckow, M., Jeffery, M., Gill, A., Evans, N., A randomised placebo-controlled trial of early treatment of the patent ductus arteriosus. Arch Dis Child Fetal Neonatal Ed 99 (2014), F99–104.
3. Aranda, J.V., Clyman, R., Cox, B., Van Overmeire, B., Wozniak, P., Sosenko, I., et al. A randomized, double-blind, placebo-controlled trial on intravenous ibuprofen L-lysine for the early closure of nonsymptomatic patent ductus arteriosus within 72 hours of birth in extremely low-birth-weight infants. Am J Perinatol 26 (2009), 235–245.
4. Cooke, L., Steer, P., Woodgate, P., Indomethacin for asymptomatic patent ductus arteriosus in preterm infants. Cochrane Database Syst Rev(2), 2003 CD003745.
5. Liebowitz, M., Koo, J., Wickremasinghe, A., Allen, I.E., Clyman, R.I., Effects of prophylactic indomethacin on vasopressor-dependent hypotension in extremely preterm infants. J Pediatr 182 (2017), 21–27.
6. Fowlie, P.W., Davis, P.G., Prophylactic intravenous indomethacin for preventing mortality and morbidity in preterm infants. Cochrane Database Syst Rev(7), 2010 CD000174.
7. Sosenko, I.R., Fajardo, M.F., Claure, N., Bancalari, E., Timing of patent ductus arteriosus treatment and respiratory outcome in premature infants: a double-blind randomized controlled trial. J Pediatr 160 (2012), 929–935 e1.
8. Ohlsson, A., Walia, R., Shah, S.S., Ibuprofen for the treatment of patent ductus arteriosus in preterm or low birth weight (or both) infants. Cochrane Database Syst Rev(2), 2015 CD003481.
9. Ohlsson, A., Shah, S.S., Ibuprofen for the prevention of patent ductus arteriosus in preterm and/or low birth weight infants. Cochrane Database Syst Rev(7), 2011 CD004213.
10. Benitz, W.E., Committee on Fetus and Newborn, American Academy of Pediatrics. Patent ductus arteriosus in preterm infants. Pediatrics 137 (2016), 1–6.
11. Schena, F., Francescato, G., Cappelleri, A., Picciolli, I., Mayer, A., Mosca, F., et al. Association between hemodynamically significant patent ductus arteriosus and bronchopulmonary dysplasia. J Pediatr 166 (2015), 1488–1492.
12. Liebowitz, M.C., Clyman, R.I., Predicting the need for home oxygen therapy in preterm infants born before 28 weeks’ gestation. Am J Perinatol 33 (2016), 34–39.
13. Clyman, R.I., Wickremasinghe, A., Merritt, T.A., Solomon, T., McNamara, P., Jain, A., et al. Hypotension following patent ductus arteriosus ligation: the role of adrenal hormones. J Pediatr 164 (2014), 1449–1455.
14. Jhaveri, N., Moon-Grady, A., Clyman, R.I., Early surgical ligation versus a conservative approach for management of patent ductus arteriosus that fails to close after indomethacin treatment. J Pediatr 157 (2010), 381–387 7 e1.
15. Koch, J., Hensley, G., Roy, L., Brown, S., Ramaciotti, C., Rosenfeld, C.R., Prevalence of spontaneous closure of the ductus arteriosus in neonates at a birth weight of 1000 grams or less. Pediatrics 117 (2006), 1113–1121.
16. Hammerman, C., Bin-Nun, A., Markovitch, E., Schimmel, M.S., Kaplan, M., Fink, D., Ductal closure with paracetamol: a surprising new approach to patent ductus arteriosus treatment. Pediatrics 128 (2011), e1618–21.
17. El-Khuffash, A., Jain, A., Corcoran, D., Shah, P.S., Hooper, C.W., Brown, N., et al. Efficacy of paracetamol on patent ductus arteriosus closure may be dose dependent: evidence from human and murine studies. Pediatr Res 76 (2014), 238–244.
18. Fenton, T.R., Kim, J.H., A systematic review and meta-analysis to revise the Fenton growth chart for preterm infants. BMC Pediatr, 13, 2013, 59.
19. Papile, L.A., Burstein, J., Burstein, R., Koffler, H., Incidence and evolution of subependymal and intraventricular hemorrhage: a study of infants with birth weight < 1500 grams. J Pediatr 92 (1978), 529–534.
20. Bell, M.J., Ternberg, J.L., Feigin, R.D., Keating, J.P., Marshall, R., Barton, L., et al. Neonatal necrotizing enterocolitis. Therapeutic decisions based upon clinical staging. Ann Surg 187 (1978), 1–7.
21. Walsh, M.C., Yao, Q., Gettner, P., Hale, E., Collins, M., Hensman, A., et al. Impact of a physiologic definition on bronchopulmonary dysplasia rates. Pediatrics 114 (2004), 1305–1311.
22. Good, W.V., Hardy, R.J., Dobson, V., Palmer, E.A., Phelps, D.L., Quintos, M., et al. The incidence and course of retinopathy of prematurity: findings from the early treatment for retinopathy of prematurity study. Pediatrics 116 (2005), 15–23.
23. Keller, R.L., Tacy, T.A., Fields, S., Ofenstein, J.P., Aranda, J.V., Clyman, R.I., Combined treatment with a non-selective nitric oxide synthase inhibitor (L-NMMA) and indomethacin increases ductus constriction in extremely premature newborns. Pediatr Res 58 (2005), 1216–1221.
24. El Hajjar, M., Vaksmann, G., Rakza, T., Kongolo, G., Storme, L., Severity of the ductal shunt: a comparison of different markers. Arch Dis Child Fetal Neonatal Ed 90 (2005), F419–22.
25. Wickremasinghe, A.C., Rogers, E.E., Piecuch, R.E., Johnson, B.C., Golden, S., Moon-Grady, A.J., et al. Neurodevelopmental outcomes following two different treatment approaches (early ligation and selective ligation) for patent ductus arteriosus. J Pediatr 161 (2012), 1065–1072.
26. Kabra, N.S., Schmidt, B., Roberts, R.S., Doyle, L.W., Papile, L., Fanaroff, A., Neurosensory impairment after surgical closure of patent ductus arteriosus in extremely low birth weight infants: results from the trial of indomethacin prophylaxis in preterms. J Pediatr 150 (2007), 229–234.
27. Sellmer, A., Bjerre, J.V., Schmidt, M.R., McNamara, P.J., Hjortdal, V.E., Host, B., et al. Morbidity and mortality in preterm neonates with patent ductus arteriosus on day 3. Arch Dis Child Fetal Neonatal Ed 98 (2013), F505–10.
28. Clyman, R., Cassady, G., Kirklin, J.K., Collins, M., Philips, J.B., The role of patent ductus arteriosus ligation in bronchopulmonary dysplasia: reexamining a randomized controlled trial. J Pediatr 154 (2009), 873–876.
29. Kaempf, J.W., Wu, Y.X., Kaempf, A.J., Kaempf, A.M., Wang, L., Grunkemeier, G., What happens when the patent ductus arteriosus is treated less aggressively in very low birth weight infants?. J Perinatol 32 (2012), 344–348.
30. Sung, S.I., Chang, Y.S., Chun, J.Y., Yoon, S.A., Yoo, H.S., Ahn, S.Y., et al. Mandatory closure versus nonintervention for patent ductus arteriosus in very preterm infants. J Pediatr 177 (2016), 66–71 e1.
31. Chang, L.Y., McCurnin, D., Yoder, B., Shaul, P.W., Clyman, R.I., Ductus arteriosus ligation and alveolar growth in preterm baboons with a patent ductus arteriosus. Pediatr Res 63 (2008), 299–302.
32. Waleh, N., McCurnin, D.C., Yoder, B.A., Shaul, P.W., Clyman, R.I., Patent ductus arteriosus ligation alters pulmonary gene expression in preterm baboons. Pediatr Res 69 (2011), 212–216.
33. Stoll, B.J., Hansen, N.I., Bell, E.F., Walsh, M.C., Carlo, W.A., Shankaran, S., et al. Trends in care practices, morbidity, and mortality of extremely preterm neonates, 1993-2012. JAMA 314 (2015), 1039–1051.
34. Lea, C.L., Smith-Collins, A., Luyt, K., Protecting the premature brain: current evidence- based strategies for minimising perinatal brain injury in preterm infants. Arch Dis Child Fetal Neonatal Ed, 2016.
35. Slaughter, J.L., Reagan, P.B., Bapat, R.V., Newman, T.B., Klebanoff, M.A., Nonsteroidal anti- inflammatory administration and patent ductus arteriosus ligation, a survey of practice preferences at US children's hospitals. Eur J Pediatr 175 (2016), 775–783.
36. Lokku, A., Mirea, L., Lee, S.K., Shah, P.S., Canadian Neonatal Network. Trends and outcomes of patent ductus arteriosus treatment in very preterm infants in Canada. Am J Perinatol, 2016.